Thus, the clinical similarities between AOS patients with variants in NOTCH1, DLL4, and RBPJ suggest that the majority of developmental defects associated with RBPJ variants that encode proteins with compromised DNA binding are likely due to decreased NOTCH1 signal strength and not due to an impact on the antagonistic co-repressors. Here, NOTCH1 is linked to Adams-Oliver syndrome.